logo

A Human (allogeneic) bone marrow derived mesenchymal stem cells 128bags,and 13 other contracts

Prospective · Japan

Source: Japan External Trade Organization (JETRO)

Tender
Prospective

Official in charge of disbursement of the procuring entity : Nagahiro Minato, President, Kyoto University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Human (allogeneic) bone marrow derived mesenchymal stem cells 128bags B Eculizumab (genetical recombination) 328vials C Ravulizumab (genetical recombination, 1100mg11mL/vial) 36vials D Ravu

Status
Closed
Sector
Hospital, Education
Location
Japan
Updated
3 Nov 2026
Source
Japan External Trade Organization (JETRO)

ConstructChat

Ask ConstructChat about A Human (allogeneic) bone marrow derived mesenchymal stem cells 128bags,and 13 other contracts

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “A Human (allogeneic) bone marrow derived mesenchymal stem cells 128bags,and 13 other contracts” is a tender record in Taiyo, linked to the Hospital sector. It is issued for works, goods, or services related to Japan.

Participants

Not available for this record.

Status

Original status

prospective

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

Official in charge of disbursement of the procuring entity : Nagahiro Minato, President, Kyoto University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Human (allogeneic) bone marrow derived mesenchymal stem cells 128bags B Eculizumab (genetical recombination) 328vials C Ravulizumab (genetical recombination, 1100mg11mL/vial) 36vials D Ravulizumab (genetical recombination, 300mg3mL/vial) 894vials E Axicabtagene Ciloleucel 22bags F Tisagenlecleucel 6bags G Onasemnogene abeparvove 1set H Nusinersen Sodium (12mg5mL/vial) 20vials I Nusinersen Sodium (28mg5mL/vial) 1vial J Nusinersen Sodium (50mg5mL/vial) 1vial K Idecabtagene vicleucel 22bags L Lisocabtagene maraleucel 36sets M Dinutuximab (Genetical Revombination) 48vials N Inebilizumab (Genetical Revombination) 30vials Delivery period : From April, 202 through 3 March, 202 Delivery place : Kyoto University Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article of the Regulation concerning the Contract for Kyoto University, B have the Grade A, Grade B or Grade C qualification during fiscal 202 in the Kinki area in sales of product for participating in tenders by Single qualification for every ministry and agency, C meet content specified in the tender documentation, D prove to have obtained the first-class license for selling drugs in accordance with the Pharmaceutical and Medical Device Act, E prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by President, F not be currently under a suspension of business order as instructed by Kyoto University. Time limit of tender : 1 : 0 2 March, 202 Contact point for the notice : Yosuke Tamura Procurement Section, Accounting Division, Kyoto University Hospital 5 Kawahara-cho Shogoin Sakyo-ku Kyoto-shi 606-850 Japan TEL 075-51-326 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.

Location

Country

Japan

Source

Source

Japan External Trade Organization (JETRO)

URL

More Details

Record type

Tender

Sector

Hospital, Education

Article published date

2026-03-26

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender